SOURCE: Novo Nordisk A/S

September 28, 2009 08:10 ET

Novo Nordisk A/S: Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - September 28, 2009) - Novo Nordisk A/S - Share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.

Since the announcement as of 21 September 2009, the following transactions have been made under the programme:


                   Number      Average     Transaction
                  of shares purchase price value, DKK
Accumulated, last
announcement      2,232,000                708,994,626
14 September 2009    75,000       326.7251  24,504,383
15 September 2009    70,000       329.8280  23,087,960
16 September 2009    85,000       324.1285  27,550,923
17 September 2009   150,500       315.6821  47,510,156
18 September 2009    70,000       317.1650  22,201,550
Accumulated under
the programme     2,682,500                853,849,597

With the transactions stated above, Novo Nordisk owns a total of 27,519,308 treasury shares, corresponding to 4.4% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 28,500 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Outside North America: Outside North America:
Mette Kruse Danielsen  Mads Veggerby Lausten
Tel: (+45) 4442 3883   Tel: (+45) 4443 7919
mkd@novonordisk.com    mlau@novonordisk.com

                       Kasper Roseeuw Poulsen
                       Tel: 4442 4471
                       krop@novonordisk.com

In North America:      In North America:
Sean Clements          Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com   hrmm@novonordisk.com

Company Announcement no 57 / 2009

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Copyright © Hugin AS 2009. All rights reserved.

Contact Information